The 4-Second Blind Spot

Mike Cymbor, OD, FAAO, discusses an enduring gap in glaucoma care that could be addressed with smart contact lenses.

By
Mike Cymbor, OD, FAAO
September 1, 2026
5 min

Optometric Management

Background

Glaucoma is a leading cause of irreversible blindness, making effective management crucial. Traditional methods of IOP measurement often fail to capture important fluctuations that occur outside of clinical visits, leading to potential mismanagement of the disease.

Data Highlights

No numerical data or trial data presented in the article.

Key Findings

Current glaucoma management often relies on IOP measurements taken during brief clinical visits, leading to a significant blind spot in patient monitoring.
Research indicates that 24-hour IOP monitoring can reveal clinically significant fluctuations that standard office measurements miss.
Experimental devices, such as those incorporating microfluidic systems, have shown promise in animal models for IOP management.
Challenges remain in ensuring the accuracy and safety of these devices for long-term use in humans.

Clinical Implications

The integration of continuous IOP monitoring technologies could enhance the management of glaucoma by providing more comprehensive data on pressure fluctuations. This may lead to more informed treatment decisions and improved patient outcomes.